Colectomy: 123 Real Stories

123 stories match colectomy. 119 of them mention surgery.

Cancer Stories

Jay, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Jay's Patient Story

Patient Info: Jay Reese, Under 40

Biomarkers: Lynch syndrome

After a full colectomy in February 2012, Jay did not need further surgery, radiation, or chemotherapy and continued close surveillance because of Lynch syndrome.

Dana-Farber
OutcomeNot reported
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Colon cancer that later spread to the testis and liver

Patient Info: Anonymized, male, 60s | Stage IV

Metastatic Site: right testis, liver

Liver metastasis was found 6 months after orchiectomy. Telephone follow-up confirmed that he survived for more than 18 months after the testicular surgery.

PubMed Central
OutcomeSetback / Progression
Savannah, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: Savannah's Survivor Story

Patient Info: Savannah Kaspar, Female, Under 40 | Stage II

Biomarkers: Lynch syndrome genetic testing negative

As of March 2024, Savannah had completed partial colectomy and 4 rounds of adjuvant chemotherapy for Stage II sigmoid colon cancer and had entered surveillance with bloodwork every 3 months.

MD Anderson
OutcomeSurvivorship / Surveillance
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

Colon cancer recurrence at a surgical drain site

Patient Info: Anonymized, Male

He recovered well after abdominal-wall excision and was followed every 3–6 months, with no clinical signs of further recurrence or metastasis.

PubMed Central
OutcomeSurvivorship / Surveillance
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

Pembrolizumab produced a complete response in unresectable dMMR colon cancer

Patient Info: Anonymized, female, 70+

Biomarkers: dMMR/MSI-H; MLH1 loss; MSH2 loss; RAS/BRAF wild type; MLH1 promoter hypermethylation

Surgery found a pathological complete response with no residual cancer in the colon or 58 lymph nodes, and follow-up showed no relapse.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Pembrolizumab led to complete response before surgery for metastatic dMMR colon cancer

Patient Info: Anonymized, male, 70+ | Stage IV

Biomarkers: dMMR/MSI-H; MLH1 loss; PMS2 loss; BRAF mutation; heterozygous MUTYH p. pathogenic variant

Metastatic Site: liver

The 2023 liver resection showed a pathological complete response with no residual tumor, and he entered follow-up without additional therapy.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

Colorectal cancer: using a blood test (ctDNA) to guide immunotherapy after surgery — Case 1

Patient Info: Anonymized, Male, 50s

Biomarkers: KRAS ; TMB 11 mutations/Mb; loss of MLH1 and PMS2; dMMR/MSI-H; germline multigene panel negative; ctDNA positive after surgery and chemotherapy

Pembrolizumab cleared ctDNA within about 3 months. After completing 1 year of immunotherapy, surveillance CT showed no evidence of disease and ctDNA remained negative.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

Colorectal cancer: using a blood test (ctDNA) to guide immunotherapy after surgery

Patient Info: Anonymized, Male, 40s

Biomarkers: dMMR/MSI-H; pathogenic germline MLH1 c.1459C>T consistent with Lynch syndrome; postoperative ctDNA rose during chemotherapy and became near-undetectable on pembrolizumab

He continued pembrolizumab with no evidence of disease on interval CT and near-undetectable ctDNA. Grade 1 thyroiditis was monitored without treatment interruption.

PubMed Central
OutcomeIn Treatment
Laura, who was diagnosed with Stage III Colorectal AdenocarcinomaColorectal Cancer

Stage III Colorectal Adenocarcinoma: Laura's Patient Story

Patient Info: Laura | Stage III

Laura completed about 6 months of chemotherapy after partial colectomy and returned to part-time work while continuing to manage fatigue.

Our Cancer Stories
OutcomeNot reported
Patricia, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Patricia's Patient Story

Patient Info: Patricia

Receiving a 6-month course of oral capecitabine while continuing ostomy care and recovery from postoperative complications.

Our Cancer Stories
OutcomeCare Ongoing
Lori, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Lori's Survivor Story

Patient Info: Lori | Stage IV

Metastatic Site: ovary

After a September 2024 recurrence and surgery in October, Lori said she was in remission and was being monitored with monthly blood work.

Our Cancer Stories
OutcomeCancer-Free / NED
Ceejay, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Ceejay's Patient Story

Patient Info: Ceejay | Stage III

After treatment, Ceejay describes feeling optimistic and hopeful while planning for retirement and new hobbies.

Our Cancer Stories
OutcomeNot reported
A patient, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

J Fletcher

Patient Info: J Fletcher | Stage II

J Fletcher was awaiting the start of planned surgery and chemotherapy after a recent Stage II colorectal cancer diagnosis.

Our Cancer Stories
OutcomeCare Ongoing